Article has an altmetric score of 4

Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases Article

Liu, Mingyu, Xie, Lulu, Zhang, Yuying et al. (2023). Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases . CELL DEATH & DISEASE, 14(1), 10.1038/s41419-023-05550-4

Open Access

cited authors

  • Liu, Mingyu; Xie, Lulu; Zhang, Yuying; Chen, Jianning; Zhang, Xiang; Chen, Ye; Huang, Wensou; Cai, Mingyue; Liang, Licong; Lai, Miaoling; Huang, Jingjun; Guo, Yongjian; Lin, Liteng; Zhu, Kangshun

sustainable development goals

authors

publication date

  • January 13, 2023

published in

keywords

  • BEVACIZUMAB
  • CANCER
  • CELLS
  • Cell Biology
  • FIBROSIS
  • GROWTH
  • INITIATE
  • Life Sciences & Biomedicine
  • PIRFENIDONE
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • SPRINGERNATURE

volume

  • 14

issue

  • 1